Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer

PURPOSE: Estrogen receptor-α (ERα) targeted therapies including tamoxifen (TAM) or Faslodex (ICI) are used to treat ER+ breast cancers. Up to 50% of tumors will acquire resistance to these interventions. Autophagy has been implicated as a major driver of antiestrogen resistance. We have explored the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cook, Katherine L., Wärri, Anni, Soto-Pantoja, David R., Clarke, Pamela A.G., Cruz, M. Idalia, Zwart, Alan, Clarke, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073207/
https://ncbi.nlm.nih.gov/pubmed/24928945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-3227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados